Category: Uncategorized

Business Television – Algernon Pharmaceuticals and the DMT/Stroke Clinical Program
Streetwise Live! – Algernon is Awaiting Approval for a Phase 1 DMT Human Stroke Study
Proactive Investors Interview – Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy for DMT Intellectual Property
Proactive Investors Interview – Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Stroke Study
This Pharmaceutical Company Has a Brilliant Concept – An Expert Opinion
Algernon Pharmaceuticals Ifenprodil Chronic Cough Study Receives Positive Feedback from U.S. FDA
Streetwise Reports – Algernon Pharmaceuticals Looks to U.S. for Help Fighting Strokes
Market One – Rethinking DMT: Algernon Pharmaceuticals’ Novel Approach to Stroke Treatment
Proactive Investors Interview – Algernon Pharmaceuticals Receives a Positive Response from U.S. FDA on SCLC Study
Upfront with Algernon Pharmaceuticals CEO Chistopher J Moreau – Episode 4

About Us

Get the skills, guidance, and resources you need to make a big difference in your contact center operations that can lead to a big difference

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.